Developing a Palladium(II) Agent to Overcome Multidrug Resistance and Metastasis of Liver Tumor by Targeted Multiacting on Tumor Cell, Inactivating Cancer-Associated Fibroblast and Activating Immune Response-Reference-Cited by-同舟云学术

Developing a Palladium(II) Agent to Overcome Multidrug Resistance and Metastasis of Liver Tumor by Targeted Multiacting on Tumor Cell, Inactivating Cancer-Associated Fibroblast and Activating Immune Response

Published:2024-09-05 Issue: Volume: Page:
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Jiang Ming¹^ORCID,Li Wenjuan¹,Liang Jinzhe²,Pang Min¹,Li Shanhe¹,Xu Gang¹,Zhu Minghui¹,Liang Hong¹,Zhang Zhenlei¹^ORCID,Yang Feng¹^ORCID

Affiliation:

1. State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources/Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Collaborative Innovation Center for Guangxi Ethnic Medicine, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin, Guangxi 541004, PR China

2. MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, Guangdong Basic Research Center of Excellence for Functional Molecular Engineering, School of Chemistry, Sun Yat-Sen University, Guangzhou 510006, PR China

Funder

Natural Science Foundation of Guangxi Zhuang Autonomous Region

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c01175

Reference68 articles.

1. Hepatocellular carcinoma: old friends and new tricks

2. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. The challenges of multi-drug-resistance in hepatology

4. Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches

5. Polymers with distinctive anticancer mechanism that kills MDR cancer cells and inhibits tumor metastasis